A
☆
EPS:
1.20
Rev:
1.8B
Net Inc:
339M
💾
💾
💾
💾
💾
Income Statement
Balance Sheet
Cash Flow
Revenue
vs Industry
Valuation
Overview
Income Statement
💾
Expenses
💾
Tax
💾
Dimension Breakdowns
us-gaap:OperatingIncomeLoss
us-gaap:StatementBusinessSegmentsAxis
Leaf Members
💾
Assets
💾
Assets (Current)
💾
Assets (Non-Current)
💾
Liabilities
💾
Liabilities (Current)
💾
Liabilities (Non-Current)
💾
Cash Flow
💾
Cash Flow Investing
💾
Cash Flow Financing
💾
Dimension Breakdowns
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
srt:ProductOrServiceAxis
Leaf Members
💾
us-gaap:StatementBusinessSegmentsAxis
Leaf Members
💾
srt:StatementGeographicalAxis
Leaf Members
💾
a:EndMarketsAxis
Leaf Members
💾
srt:StatementGeographicalAxis, us-gaap:StatementBusinessSegmentsAxis
Top Products (by latest quarter)
💾
A vs
Diagnostics & Research
(7 peers) - Healthcare
Gross Margin
52.2%
+7.0pp vs peers
Operating Margin
20.6%
+34.2pp vs peers
Net Margin
18.3%
+31.8pp vs peers
Gross Margin
Operating Margin
Net Margin
💾
Related:
MTD
IDXX
LH
WAT
IQV
ILMN
DHR
TMO
DGX
TWST
